Abstract
Most gene therapy research to date has focused on solving the delivery problem – getting genes efficiently and stably into target cells and tissues. Those working on systems for regulating the expression of genes once delivered have often been accused of trying to run before they can walk. Yet regulation is likely to be essential if gene therapy is to realize its full potential as a mainstream clinical option for delivering proteins. Dramatic progress has been made in designing and testing systems in which expression is controlled by orally active drugs. The next few years should see the first clinical trials of drug-regulated gene therapies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Varley AW, Munford RS . Physiologically responsive genetherapy Molec Med Today 1998 4: 445–451
Clackson T . Controlling mammalian gene expression with small molecules Curr Opin Chem Biol 1997 1: 210–218
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc Natl Acad Sci USA 1992 89: 5547–5551
Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells Science 1995 268: 1766–1769
No D, Yao TP, Evans RM . Ecdysone-inducible gene expression in mammalian cells and transgenic mice Proc Natl Acad Sci USA 1996 93: 3346–3351
Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW . A regulatory system for use in gene transfer Proc Natl Acad Sci USA 1994 91: 8180–8184
Rivera VM et al. A humanized system for pharmacologic control of gene expression Nature Med 1996 2: 1028–1032
Ho SN et al. Dimeric ligands define a role for transcriptional activation domains in reinitiation Nature 1996 382: 822–826
Amara JF et al. A versatile synthetic dimerizer for the regulation of protein–protein interactions Proc Natl Acad Sci USA 1997 94: 10618–10623
Magari SR et al. Pharmacologic control of a humanized gene therapy system implanted into nude mice J Clin Invest 1997 100: 2865–2872
Spencer DM . Creating conditional mutations in mammals Trends Genet 1996 12: 181–187
Pomerantz JL, Sharp PA, Pabo CO . Structure-based design of transcription factors Science 1995 267: 93–96
Liberles SD, Diver ST, Austin DJ, Schreiber SL . Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen Proc Natl Acad Sci USA 1997 94: 7825–7830
Clackson T et al. Inducible gene expression in vivo using non-immunosuppressive analogs of rapamycin. (Submitted)
Bohl D, Heard JM . Modulation of erythropoietin delivery from engineered muscles in mice Hum Gene Ther 1997 8: 195–204
Bohl D, Naffakh N, Heard JM . Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts Nature Med 1997 3: 299–305
Rizzuto G et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation Proc Natl Acad Sci USA 1999 96: 6417–6422
Ho DY, McLaughlin JR, Sapolsky RM . Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system Mol Brain Res 1996 41: 200–209
Burcin MM et al. Adenovirus-mediated regulable target gene expression in vivo Proc Natl Acad Sci USA 1999 96: 355–360
Rendahl KG et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors Nat Biotechnol 1998 16: 757–761
Bohl D, Salvetti A, Moullier P, Heard JM . Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector Blood 1998 95: 1512–1517
Rivera VM et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer Proc Natl Acad Sci USA 1999 96: 8657–8662
Ye X et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer Science 1999 283: 88–91
Natesan S et al. A general strategy to enhance the potency of chimeric activation activators Proc Natl Acad Sci USA 1999 96: 13898–13903
Gossen M, Bujard H . Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells Nucleic Acids Res 1993 21: 4411–4412
Riddell SR et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients Nature Med 1996 2: 216–223
White S et al. Recognition of the four Watson–Crick base pairs in the DNA minor groove by synthetic ligands Nature 1998 391: 468–471
Nyanguile O, Uesugi M, Austin DJ, Verdine GL . A nonnatural transcriptional coactivator Proc Natl Acad Sci USA 1997 94: 13402–13406
Werstuck G, Green MR . Controlling gene expression in living cells through small molecule–RNA interactions Science 1998 282: 296–298
Rivera VM et al. Pharmacological regulation of therapeutic protein secretion in vivo through controlled aggregation in the endoplasmic reticulum Science 2000 (in press)
Acknowledgements
I thank all my ARIAD colleagues and collaborators for discussions and enlightenment, and Vic Rivera for critical review of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clackson, T. Regulated gene expression systems. Gene Ther 7, 120–125 (2000). https://doi.org/10.1038/sj.gt.3301120
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301120
Keywords
This article is cited by
-
Control of mammalian gene expression by modulation of polyA signal cleavage at 5′ UTR
Nature Biotechnology (2024)
-
A step closer to safe and efficient mammalian gene regulation
Nature Biotechnology (2024)
-
Single vector non-leaky gene expression system for Drosophila melanogaster
Scientific Reports (2017)
-
Ecdysone Receptor-based Singular Gene Switches for Regulated Transgene Expression in Cells and Adult Rodent Tissues
Molecular Therapy - Nucleic Acids (2016)
-
Human fetal liver cells for regulated ex vivo erythropoietin gene therapy
Molecular Therapy - Methods & Clinical Development (2014)